Fremanezumab Suppliers & Bulk Manufacturers
Available Forms: Prefilled syringe
Available Strengths: 225 mg / 1.5 mL
Reference Brands: Ajovy (USA/EU)
Category:
Neurology
Fremanezumab is a monoclonal antibody that targets the CGRP receptor, a protein involved in the transmission of pain and the development of migraines. By inhibiting this receptor, fremanezumab helps to prevent the onset of migraine attacks. It is administered via subcutaneous injection, with dosing options tailored to patient needs and preferences.
Fremanezumab is available in Prefilled syringe
and strengths such as 225 mg / 1.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fremanezumab is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fremanezumab can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing